(lp0
S'The GenVec, Inc.  Cut to Hold at HC Wainwright Petro Global News 24 - Jan 31, 2017 Other analysts have also recently issued reports about the company. Zacks Investment Research upgraded GenVec from a hold rating to a buy rating and set a $5.00 price target on the stock in a research report on Wednesday, October 5th.'
p1
aS'SHAREHOLDER ALERT: Rigrodsky &amp; Long, P.A. Files Class Action Suit Against ... GlobeNewswire  - 10 hours ago Rigrodsky &amp; Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of GenVec, Inc.   common stock in connection with the proposed&nbsp;...'
p2
aS'5.92 MarketWatch - Dec 21, 2009 GenVec Inc. Watchlist CreateGNVCAlert. Closed. Last Updated: Apr 13, 2017 3:59 p.m.. $ 5.92. 0.11 1.89%. Previous Close.'
p3
aS'GenVec Inc  Is Another Low Float Runner Insider Financial - Jan 11, 2017 Low floats have been the name of the game for a number of biotech companies this week, with some seemingly inexplicable runs only explained by low float, high-volume spikes.'
p4
aS'Intrexon to acquire fellow Md. biotech Washington Business Journal - Jan 24, 2017 Germantown-based Intrexon Corp. is swallowing up its fellow Montgomery County biotech, GenVec Inc., a small Gaithersburg gene therapy company that has been struggling to grow since its lead cancer drug candidate failed in late-stage trials in 2010.GenVec Inc.  Is Up Sharply After Bought By Intrexon - RTT NewsIntrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform - PR Newswire '
p5
aS"Here's Who Just Picked Up Genvec Inc.  Shares Small Cap Exclusive  - Feb 17, 2017 For those not familiar with the company, GenVec, Inc.  is a clinical-stage biopharmaceutical company, engaged in the development of therapeutics and vaccines."
p6
aS'GenVec Inc. GNVC  Wall Street Journal - Feb 12, 2011 News GenVec Inc.GNVC. Significant News Only. 03/09/17; Press Release. Research Reports Initiation on Biotech Stocks -- Alnylam Pharma, INSYS Therapeutics, Curis, and GenVec.'
p7
aS'GenVec, Inc. , Interview with Doug Swirsky, CEO Nasdaq - Feb 24, 2015 GenVec is a pioneer in the design, testing and manufacture of adenovectored product candidates that can deliver on the promise of gene-based medicine.'
p8
aS'GenVec Provides Update on Hearing Loss Clinical Program PR Newswire  - May 2, 2016 GAITHERSBURG, Md., May 2, 2016 /PRNewswire/ -- GenVec, Inc. , a clinical-stage gene delivery company, announced today that it was notified by its collaborator Novartis that the Data Safety Monitoring Board  for the Phase 1/2&nbsp;...'
p9
aS'200% Gain For GenVec In Sight Following January 5 Announcement Benzinga - Jan 10, 2017 Shares of GenVec Inc  are set to record 200-percent gains after signing an option deal last week with Washington University in St. Louis.'
p10
a.